ABOUT US / MEDTECH

INVESTING IN LIFE-IMPROVING MEDICAL INNOVATION

BACKING ENTREPRENEURS WITH THE VISION TO IMPROVE HEALTHCARE

MedTech is a dynamic and innovative industry, dedicated to creating digitally-enabled healthcare that saves and improves lives. MedTech start-ups that form part of the Consilience Ventures portfolio gain the investment and invaluable access to expertise that helps them conduct their clinical research and achieve their business ambitions.

MEDTECH COMMITTEE

Our MedTech Committee defines our strategy for investing in MedTech start-ups and is directly responsible for managing the lifecycle of portfolio companies. The committee oversees every aspect of bringing companies into the portfolio, including identifying high potential businesses, conducting assessments and due diligence, identifying potential roadblocks and solutions, and working closely with founders to develop a roadmap and deliverables based on our Sprint Financing model. The committee also works to identify exceptional technical experts from the Consilience Ventures Global Expert Network who can help portfolio companies reach their potential.

COMMITTEE MEMBERS

DR DEEPAK KOTAK

COMMITTEE LEAD

Deepak leads the MedTech Committee and has been working with early-stage BioTech, MedTech and consumer health companies for more than a decade. Deepak has an extensive medical background, including as a NHS teaching hospital consultant in intensive care medicine, anaesthesia and major trauma, as well as a broad range of clinical speciality experience. Deepak has a flexible, analytical and entrepreneurial approach, with a keen ability to refine key medical and clinical science issues into commercialisation and growth strategies

Stephen is a pioneer in researching human stem cell biology and regenerative medicine and has held a number of high-profile roles including Chief Scientist and Global Head of R&D for GE Healthcare and Director of Stem Cell Biology Laboratory at Kings College London, where he lectured in Biomolecular Science. Stephen is also the founder of SLM Blue Skies Innovations, providing expert analysis in emerging healthcare technologies for BioTech frims and the investment community.

DR STEPHEN MINGER

COMMITTEE MEMBER

DR RADOUANE OUDRHIRI

COMMITTEE MEMBER

Radouane is our Chief Data Scientist and one of the co-founders of Consilience Ventures. He oversees our quantitative/economic modelling and data science/AI solutions and has a background in formal logic, software engineering and data-science. Radouane is a serial entrepreneur – having built ten start-ups from scratch – and specialises in shaping the technological vision of deep-tech start-ups.

Claire has co-founded and led several life sciences ventures, including Vastmindz, which deploys remote diagnostic products to offer access to precision health and wellness knowledge. She is the CEO of Mentis Cura, a NeuroTech platform company, using data to improve and save patients’ lives through early, accurate diagnosis and intervention in central nervous system diseases and disorders. Claire is a member of the Tech London Advocates Health Working Group; an Advisory Board Member of Cambridge Innovation Academy and a fellow of the RSA.

DR CLAIRE BUTTON

COMMITTEE MEMBER

DOMINIC O’REGAN

COMMITTEE MEMBER

Dominic has extensive experience working with pharmaceutical, biotech, scientific instrument and other life science businesses. He currently helps seed and Series A stage companies go to market, gain funding or commercialise towards exit. Dominic specialises in business strategy and tactics, route to market planning, competitive intelligence, instigating partnerships and specific projects such as grant applications. He is also an angel and listed company investor specifically within UK and international life science and impact companies.

WANT TO KNOW MORE?

EXPERT SELECTION

Want to learn more about our expert selection process?
Click on our infographic below

START-UP SELECTION

Want to learn more about our start-up selection process?
Click on our infographic below

GAP ANALYSIS

Want to learn more about our gap analysis process?
Click on our infographic below

SPRINT ROADMAP

Want to learn more about our sprint roadmap process?
Click on our infographic below

LATEST FROM CONSILIENCE VENTURES

1/

MADDYNESS

In the ever-growing investment landscape, funds are multiplying and diversifying, and for startups there is more to raising investment than the money and With #QVCS Maddyness…

RESOURCES - IN THE NEWS

2/

MADDYNESS

The venture capital industry’s model has remained the same despite an influx of assets. Could digital currency signify a way around extensive funding…

RESOURCES - IN THE NEWS

3/

FORBES

It’s not difficult to assemble a list of charges against the venture capital investment model.
Let’s start with the profile of those who attracts equity finance…

NEWS - IN THE PRESS